MiniMed Group IPO: revenue, losses and offering terms from its S-1
MiniMed Group priced its IPO at $20 a share on 6 Mar 2026 and raised $560 million. Its shares trade on Nasdaq as MMED. Revenue was $2.7 billion in 2025, up 10% from 2024, with a net loss of $198 million.
Headlines
- Revenue, 2025
- $2.7B
- Up 10% on the year before
- Net loss, 2025
- $198M
- Revenue, 6 months to Oct 2025
- $1.5B
- Up 15% on a year earlier
- IPO price
- $20
- $560M raised
MiniMed Group IPO terms
From the final prospectus (424B4).
- Exchange
- Nasdaq Global Select Market
- Ticker
- MMED
- IPO price
- $20
- Shares offered
- 28,000,000
- Raised
- $560M
- Registered
- $902M, the amount the filing fee is paid on
- Underwriters
- Goldman Sachs & Co. LLC, BofA Securities and Citigroup, with 9 more banks
- First filed
- 19 Dec 2025
MiniMed Group revenue and profit
| Period | Revenue | Operating income | Net income |
|---|---|---|---|
| 2024 | $2.5B | - | - |
| 2025 | $2.7B | - | -$198M |
| 6 months to Oct 2024 | $1.3B | - | - |
| 6 months to Oct 2025 | $1.5B | - | -$21M |
MiniMed Group share structure and company facts
- Headquarters
- Northridge, California
MiniMed Group shares since the IPO
Latest close 26 Oct 2026
- IPO price
- $20
- Priced 6 Mar 2026
- First close
- $18.49
- -8% on the IPO price
- Latest close
- $18.66
- -7% on the IPO price
MiniMed Group's IPO filings
The registration statement, each amendment and the final prospectus, oldest first.
About the data
- Terms and financials are read from MiniMed Group's newest prospectus (424B4 filed 6 Mar 2026) by a Kadoa workflow. Check figures that matter against the filing.
- Registered is the amount the filing fee is paid on, often a placeholder before the price range is set.
- Raised is the IPO price times the shares sold, without the underwriters' option. Trading compares the first and latest close with the IPO price.